David F. Welch - 05 Sep 2024 Form 4 Insider Report for Infinera Corp

Role
Director
Signature
/s/ Nicholas Janof, by Power of Attorney
Issuer symbol
N/A
Transactions as of
05 Sep 2024
Net transactions value
-$19,723
Form type
4
Filing time
06 Sep 2024, 17:02:32 UTC
Previous filing
09 Jul 2024
Next filing
08 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INFN Common Stock Options Exercise $0 +8,333 +2% $0.000000 419,011 05 Sep 2024 See Footnote F1
transaction INFN Common Stock Tax liability $19,723 -3,176 -0.76% $6.21 415,835 05 Sep 2024 See Footnote F1, F2
holding INFN Common Stock 2,500 05 Sep 2024 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFN Restricted Stock Units Options Exercise $0 -8,333 -33% $0.000000 16,667 05 Sep 2024 Common Stock 8,333 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee.
F2 Represents shares that have been withheld by Infinera Corporation (the "Company") to satisfy tax withholding and remittance obligations in connection with the net settlement of vested restricted stock units ("RSUs").
F3 These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
F4 Each RSU represents a contingent right to receive one share of common stock of the Company.
F5 These RSUs, originally for a total of 100,000 shares, vest as to one-third of the shares on the one-year anniversary of the March 5, 2022 vesting commencement date, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney